MX2018009370A - Regulacion de expresion genica a través de poliadenilacion modulada por aptámeros. - Google Patents

Regulacion de expresion genica a través de poliadenilacion modulada por aptámeros.

Info

Publication number
MX2018009370A
MX2018009370A MX2018009370A MX2018009370A MX2018009370A MX 2018009370 A MX2018009370 A MX 2018009370A MX 2018009370 A MX2018009370 A MX 2018009370A MX 2018009370 A MX2018009370 A MX 2018009370A MX 2018009370 A MX2018009370 A MX 2018009370A
Authority
MX
Mexico
Prior art keywords
aptamer
gene expression
polyadenylation
regulation
modulated
Prior art date
Application number
MX2018009370A
Other languages
English (en)
Inventor
Guo Xuecui
J Volles Michael
F Danos Olivier
Original Assignee
Meiragtx Uk Ii Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiragtx Uk Ii Ltd filed Critical Meiragtx Uk Ii Ltd
Publication of MX2018009370A publication Critical patent/MX2018009370A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0066—Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Developing Agents For Electrophotography (AREA)

Abstract

La invención proporciona construcciones de polinucleótidos para regular la expresión génica mediante modulación a base de aptámeros de la supresión de poliadenilación mediada por RNPpn Ul, así como métodos para utilizar las construcciones para regular la expresión génica en respuesta a la presencia o ausencia de un ligando que se una al aptámero. La construcción de polinucleótidos contiene un punto de unión U1 en el contexto de un riborregulador que comprende una región efectora y un aptámero, de modo tal que, al unir el aptámero a un ligando, se produzca la expresión del gen objetivo.
MX2018009370A 2016-02-02 2017-02-02 Regulacion de expresion genica a través de poliadenilacion modulada por aptámeros. MX2018009370A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662290200P 2016-02-02 2016-02-02
PCT/US2017/016279 WO2017136591A1 (en) 2016-02-02 2017-02-02 Regulation of gene expression through aptamer-modulated polyadenylation

Publications (1)

Publication Number Publication Date
MX2018009370A true MX2018009370A (es) 2018-11-12

Family

ID=59500159

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018009370A MX2018009370A (es) 2016-02-02 2017-02-02 Regulacion de expresion genica a través de poliadenilacion modulada por aptámeros.

Country Status (14)

Country Link
US (2) US11697815B2 (es)
EP (1) EP3411081A4 (es)
JP (1) JP7184649B2 (es)
KR (1) KR20180117630A (es)
CN (1) CN109511259B (es)
AU (1) AU2017213835C1 (es)
BR (1) BR112018015819A2 (es)
CA (1) CA3048620A1 (es)
EA (1) EA201891721A1 (es)
MX (1) MX2018009370A (es)
MY (1) MY197192A (es)
PH (1) PH12018501650A1 (es)
SG (1) SG11201806605RA (es)
WO (1) WO2017136591A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017083747A1 (en) * 2015-11-12 2017-05-18 Baylor College Of Medicine Exogenous control of mammalian gene expression through aptamer-mediated modulation of polyadenylation
CN115698292A (zh) 2020-03-24 2023-02-03 梅里特斯英国第二有限公司 与硫胺类似物和衍生物结合的适体
WO2022015513A2 (en) 2020-07-13 2022-01-20 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods to assess rna stability
WO2022047427A2 (en) * 2020-08-31 2022-03-03 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for producing rna constructs with increased translation and stability
WO2023131811A2 (en) 2021-12-15 2023-07-13 Meiragtx Uk Ii Limited Polycistronic expression of gut peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6692910B2 (en) 1997-07-28 2004-02-17 The University Of Connecticut Inhibition of a target messenger RNA with a modified U1 small nuclear RNA
US7563601B1 (en) 2005-06-01 2009-07-21 City Of Hope Artificial riboswitch for controlling pre-mRNA splicing
GB0701722D0 (en) * 2007-01-30 2007-03-07 Scottish Crop Res Inst Inhibition of gene expression
US9441221B2 (en) * 2007-03-30 2016-09-13 Rutgers, The State University Of New Jersey Compositions and methods for gene silencing
WO2008121963A2 (en) * 2007-03-30 2008-10-09 Rutgers, The State University Of New Jersey Compositions and methods for gene silencing
WO2010132665A1 (en) * 2009-05-15 2010-11-18 Yale University Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
US9125931B2 (en) 2010-04-06 2015-09-08 Massachusetts Institute Of Technology Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
ES2785274T3 (es) * 2012-07-05 2020-10-06 Univ Pennsylvania La RNPsn U1 regula la expresión génica y modula la oncogenicidad
RS61924B1 (sr) * 2015-02-02 2021-06-30 Meiragtx Uk Ii Ltd Regulacija genske ekspresije putem aptamerom posredovane modulacije alternativnog splajsovanja
JP7089502B2 (ja) * 2016-08-03 2022-06-22 メイラジーティーエックス・ユーケー・ザ・セカンド・リミテッド アプタマーのためのハイスループット細胞系スクリーニング

Also Published As

Publication number Publication date
EP3411081A4 (en) 2019-12-11
EA201891721A1 (ru) 2019-02-28
KR20180117630A (ko) 2018-10-29
CA3048620A1 (en) 2017-08-10
WO2017136591A1 (en) 2017-08-10
PH12018501650A1 (en) 2019-06-03
SG11201806605RA (en) 2018-09-27
JP2019503204A (ja) 2019-02-07
CN109511259B (zh) 2023-10-20
BR112018015819A2 (pt) 2019-01-02
CN109511259A (zh) 2019-03-22
AU2017213835B2 (en) 2024-02-01
US20200017858A1 (en) 2020-01-16
AU2017213835C1 (en) 2024-04-18
MY197192A (en) 2023-05-31
US20240191239A1 (en) 2024-06-13
JP7184649B2 (ja) 2022-12-06
AU2017213835A1 (en) 2018-09-06
EP3411081A1 (en) 2018-12-12
US11697815B2 (en) 2023-07-11

Similar Documents

Publication Publication Date Title
PH12018501650A1 (en) Regulation of gene expression through aptamer-modulated polyadenylation
IL273058A (en) Compositions and methods for modulation of PKK expression
PH12017502180A1 (en) Tau-binding antibodies
MX2020005213A (es) Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos.
MX2021009309A (es) Modulacion de la actividad del complemento.
PH12017502207A1 (en) Tau-binding antibodies
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
PL3137530T3 (pl) Utwardzalne wodne dyspersje poliuretanowe wytwarzane z surowców odnawialnych
MX2021006626A (es) Marcadores geneticos para predecir la reactividad a terapia con agente que eleva la lipoproteina de alta densidad (hdl) o que imita la lipoproteina de alta densidad (hdl).
PH12018501651A1 (en) Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes
GB2556240B (en) Telluric referencing for improved electromagnetic telemetry
MY180166A (en) Cosmic quenchers
MX2016016233A (es) Anticuerpos anti-lgr5 y sus usos.
EP3140429A4 (en) Methods and compositions for scd, crt, crt-d, or sca therapy identification and/or selection
IL258505A (en) Self-biodegradable missile
MX2019009972A (es) Regulación de la expresión génica de señales de poliadenilación por accesibilidad mediada por aptámeros.
PH12017500794A1 (en) Herbicidal composition containing penoxsulam
GB201704683D0 (en) Electromagnetic assembley
MX2020003440A (es) Red de seguridad.
EP3254258A4 (en) Social engineering simulation workflow appliance
GB201410876D0 (en) Balance and compensation control
GB201511831D0 (en) Energy generating outfit
GB201414648D0 (en) Cash point ect cards
GB201411682D0 (en) Fire smart
ZA201500073B (en) Financial transaction system